Exelixis Inc (EXEL)

Health Care ยท Biological Products, (No Diagnostic Substances)

Exelixis Inc (EXEL) is listed on Nasdaq, where its shares have traded since April 11, 2000. SentiSense covers Exelixis Inc in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances). Michael M. Morrissey is its chief executive officer. The company reports 1,077 employees, and its corporate website is www.exelixis.com.

About Exelixis Inc

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 741 institutions reported holding EXEL, with 258.4 million shares worth $14.0 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Farallon Capital Management. Of the 5 largest reported holders, 1 added shares and 4 reduced their positions during the quarter.

More on EXEL

  • EXEL sentiment: whether news and social coverage of Exelixis Inc leans bullish or bearish, and the stories driving it.
  • EXEL ownership: all 741 reporting institutions, plus insider and congressional trades.
  • EXEL financials: revenue, net income, operating margin and free cash flow by quarter and year.

SentiSense also tracks daily options readings for Exelixis Inc: IV rank, put/call percentile, 25-delta skew and open-interest walls.

Frequently asked questions

What does Exelixis Inc do?

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer.

What sector is EXEL in?

SentiSense classifies Exelixis Inc in the Health Care sector, and its Standard Industrial Classification is Biological Products, (No Diagnostic Substances).

Where does EXEL stock trade?

Exelixis Inc (EXEL) is listed on Nasdaq, where its shares have traded since April 11, 2000.

Who is the CEO of Exelixis Inc?

Michael M. Morrissey is the chief executive officer of Exelixis Inc.